Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hilleman Laboratories Pvt. Ltd.

https://www.hillemanlabs.org/

Latest From Hilleman Laboratories Pvt. Ltd.

Expert View: Second, Third Wave COVID-19 Vaccines Still Have Much To Vie For

In a broad-ranging interview with Scrip, the ex-CEO of India's Hilleman Laboratories compares the profiles of leading COVID-19 vaccines and urges caution around how far some of the new data now rolling out should be interpreted. The executive also outlines solutions to tackle logistics issues and "vaccine hesitancy" in countries like India.

Research & Development Coronavirus COVID-19
See All

Company Information

  • Industry
  • Academic and Research Institutions
UsernamePublicRestriction

Register